These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 6895134
1. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)]. Neumann E. Wien Klin Wochenschr; 1981 Feb 20; 93(4):134-7. PubMed ID: 6895134 [Abstract] [Full Text] [Related]
2. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A, Ambrosetti A, Todeschini G, Cetto G, Perona G, Cellerino R. Cancer Treat Rep; 1984 Feb 20; 68(7-8):947-51. PubMed ID: 6204754 [Abstract] [Full Text] [Related]
3. Pediatric Hodgkin's disease. Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM. J Ky Med Assoc; 2004 Mar 20; 102(3):104-6. PubMed ID: 15067795 [Abstract] [Full Text] [Related]
4. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer. Carde P, Hayat M, Cosset JM, Somers R, Burgers JM, Sizoo W, Meerwaldt JH, Hagenbeek A, Monconduit M, van der Schueren E. NCI Monogr; 1988 Mar 20; (6):303-10. PubMed ID: 3352775 [Abstract] [Full Text] [Related]
5. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Salloum E, Doria R, Farber LR, Roberts KB, Cooper DL. Cancer J Sci Am; 1995 Mar 20; 1(4):267-73. PubMed ID: 9166487 [Abstract] [Full Text] [Related]
6. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]. Brun B, Alaoui Y, Kuentz M, Baillet F, Maylin C, Vernant JP, Reyes F, Rochant H, Pierquin B, Dreyfus B. Ann Med Interne (Paris); 1980 Mar 20; 131(4):239-43. PubMed ID: 7425449 [Abstract] [Full Text] [Related]
7. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C. Haematologica; 1998 Sep 20; 83(9):812-23. PubMed ID: 9825578 [Abstract] [Full Text] [Related]
8. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)]. Osieka R, Bruntsch U, Gallmeier WM, Seeber S, Schmidt CG. Dtsch Med Wochenschr; 1976 Aug 06; 101(32):1177-82. PubMed ID: 59661 [Abstract] [Full Text] [Related]
9. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY. Ai Zheng; 2006 Aug 06; 25(8):1013-8. PubMed ID: 16965685 [Abstract] [Full Text] [Related]
12. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center]. Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM. Sangre (Barc); 1998 Jun 06; 43(3):179-84. PubMed ID: 9741222 [Abstract] [Full Text] [Related]
13. [Hodgkin's disease in children: long-term therapeutic results (author's transl)]. Cramer P, Schaison G, Andrieu JM, Boiron M, Bernard J. Bull Cancer; 1981 Jun 06; 68(5):456-64. PubMed ID: 6800427 [Abstract] [Full Text] [Related]
14. [Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)]. Denz H, Lechleitner M, Peschel C, Peer L, Huber H. Wien Klin Wochenschr; 1983 May 13; 95(10):326-32. PubMed ID: 6688488 [Abstract] [Full Text] [Related]
15. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma. Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Kokoris SI, Kyrtsonis MC, Tsaftaridis P, Karkantaris C, Anargyrou K, Boutsis DE, Variamis E, Michalopoulos T, Boussiotis VA, Panayiotidis P, Papavassiliou C, Pangalis GA. Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):765-81. PubMed ID: 15183480 [Abstract] [Full Text] [Related]
16. [Polychemotherapy of Hodgkin's disease (author's transl)]. Jacquillat CL, Weil M, Auclerc G, Delbrück H, Chastang CL, Chelloul N, Boiron M, Bernard J. Dtsch Med Wochenschr; 1975 Apr 11; 100(15):785-90. PubMed ID: 1122828 [Abstract] [Full Text] [Related]
17. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease]. Aghai E, Kende G, Many A, Ramot B. Harefuah; 1974 Apr 01; 86(7):348-51. PubMed ID: 4846045 [No Abstract] [Full Text] [Related]
18. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ. Ai Zheng; 2007 Dec 01; 26(12):1360-4. PubMed ID: 18076802 [Abstract] [Full Text] [Related]
19. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages? Andrieu JM, Colonna P. J Clin Oncol; 1998 Jun 01; 16(6):2283. PubMed ID: 9626234 [No Abstract] [Full Text] [Related]